Clinical Trial Update: Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of oxaliplatin and capecitabine in patients with colorectal cancer, appendiceal cancer, or small intestine cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer
• Small Intestine Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma of the Appendix, Colorectal Cancer | Phase 1 | Status: COMPLETED